Live from the NIH registry
Studies recruiting near Baltimore right now
Top 25 of 1,650 recruiting studies, sorted by proximity — each links to its official registry page
Human Craniomaxillofacial Allotransplantation
Facial Injuries, Traumatic Wounds and Injuries
Phase 2
Interventional 15 participants sought
Johns Hopkins University School of Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
N/A
Interventional 168 participants sought
The Johns Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Sinai Hospital of Baltimore — Baltimore, Maryland (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Sameek Roychowdhury
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Barry J. Reiner, MD LLC — Baltimore, Maryland (1.0 mi)
· Sponsor: Medtronic MiniMed, Inc.
Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors
Smoking Cessation
N/A
Interventional 7 participants sought
Johns Hopkins Bloomberg School of Public Health — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Maryland/Greenebaum Cancer Center — Baltimore, Maryland (1.0 mi)
· Sponsor: SWOG Cancer Research Network
Extracorporeal Photopheresis in Sezary Syndrome
Sezary Syndrome
N/A
Observational 20 participants sought
Cutaneous Translational Research Program - Johns Hopkins Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Oleg E. Akilov, MD, PhD
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — Baltimore, Maryland (1.0 mi)
· Sponsor: GlaxoSmithKline
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Westat
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins — Baltimore, Maryland (1.0 mi)
· Sponsor: Relay Therapeutics, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Baltimore, Maryland (1.0 mi)
· Sponsor: AstraZeneca
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Multiple Sclerosis
Phase 2
Interventional 120 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Human Upper Extremity Allotransplantation
Amputation, Traumatic, Wounds and Injuries
Phase 2
Interventional 30 participants sought
Johns Hopkins University School of Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Escitalopram and Language Intervention for Subacute Aphasia
Aphasia, Stroke
Phase 2
Interventional 88 participants sought
Johns Hopkins School of Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: University of Alabama at Birmingham
Photobiomodulation and Tooth Analgesia
Dental Anaesthesia, Dental Pain
N/A
Interventional 200 participants sought
University of Maryland School of Dentistry, Pediatric Clinics — Baltimore, Maryland (1.0 mi)
· Sponsor: University of Maryland, Baltimore
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
Phase 1, Phase 2
Interventional 304 participants sought
Research Site — Baltimore, Maryland (1.0 mi)
· Sponsor: AstraZeneca
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Capitol Cardiology Associates PA — Lanham, Maryland (26.8 mi)
· Sponsor: Duke University
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Head and Neck Cancer, Squamous Cell Carcinoma
Phase 2
Interventional 75 participants sought
Johns Hopkins Hospital East Baltimore — Baltimore, Maryland (1.0 mi)
· Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
Vascular Malformations, VM - Vascular Malformation
N/A
Observational 200 participants sought
Johns Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
The Retina Care Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
Kennedy Krieger Institute — Baltimore, Maryland (1.0 mi)
· Sponsor: AskBio Inc
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Annapolis, Maryland (23.5 mi)
· Sponsor: AstraZeneca
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis
Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring, Fragility Fracture
N/A
Interventional 48 participants sought
University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center — Baltimore, Maryland (1.0 mi)
· Sponsor: University of Southern California